Biologics have transformed the treatment of many high-burden causing diseases, improving the lives of thousands of patients. But the development and production of these complex therapies, also known as large molecules drug products, entail specialized expertise and very specific technology.
As we aim to be partner in biopharma to support the development of innovative products and transformative manufacturing methods, we are proud to announce that DFE Pharma has joined LyoHub, the advanced lyophilization technology consortium based out of Purdue University in Indiana.
LyoHub brings together university, federal and industry partners to:
- make critical and transformative advances in using freeze-drying and lyophilization techniques for food and pharmaceutical production
- identify and share best practices for lyophilization
- conduct applied research to improve processes and products in this field.
By working together and sharing our expertise with LyoHub, we can further help our biopharmaceutical customers provide patients with the best treatments for their unmet health needs.
“Our decision to join Lyohub is driven by the opportunity to better understand how our products can support advanced lyophilization processes and practices” explains Mark Wagner, DFE Pharma BioPharma Sales Manager. “With this knowledge, we can empower our customers and deliver best-in-class excipients designed to overcome the challenges of emerging technologies.”